We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Heat-Activated Skin Patch Targets Melanoma Lesions

By HospiMedica International staff writers
Posted on 06 Apr 2026

Melanoma, a lethal skin cancer, is usually managed with surgical excision. More...

Surgery can be invasive and may not be suitable for all lesions, driving interest in noninvasive therapies. Researchers have now developed a flexible, heat-activated skin patch intended to kill melanoma cells while sparing surrounding tissue. The approach aims to target tumor cells beneath the patch and limit spread.

The stretchable, bandage-like device incorporates laser-induced graphene, a laser-etched porous carbon scaffold, loaded with copper(II) oxide and embedded in a silicone polymer. When positioned over a lesion, the patch conforms to skin, remains breathable, and is chemically inert until activation. The work was published in ACS Nano on March 5, 2026.

Activation is achieved by gently warming the patch with a low-power laser to 108 degrees Fahrenheit (42 degrees Celsius). Under these conditions, the material releases copper ions that interact with cancer cell DNA and induce oxidative stress, leading to cell death. The same pathway is expected to trigger an immune response that inhibits tumor cell migration and potential metastasis.

In laboratory studies, investigators placed the patch over cultured melanoma cells and applied heat to initiate ion release. The activated patch killed most melanoma cells directly beneath it and slowed cellular movement. Surrounding conditions were maintained without evidence of collateral damage in the culture model.

A preliminary 10-day study in mice evaluated in vivo performance. Patches applied to melanoma lesions were activated for one hour on days 1 and 5. The treatment reduced melanoma lesions by 97%, and tissue analyses showed no cancer cell migration beyond tumor borders and no copper accumulation in organs or blood.

The researchers report that the device is reusable and straightforward to administer. Based on these early findings, the technology could someday be adapted for targeted, safe, and efficient noninvasive melanoma treatment in humans.


New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Wound Irrigation Solution
Prontosan®
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The device combines a minimally invasive, long‑lifetime “read/write” brain‑computer interface (BCI) with assistive devices and AI-driven support (photo courtesy of Epia Neuro)

Implantable Brain-Computer Interface Supports Stroke Recovery and Assistive Function

Stroke leaves many survivors with chronic motor deficits that limit independence, and cognitive decline is a growing concern in aging populations. Stroke is a leading cause of long-term disability in the... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.